Brief: Wockhardt Initiates Strategic Realignment Of US Operations To Focus On Innovative Portfolio
11/07/2025 12:23
July 11 (Reuters) - Wockhardt Ltd WCKH.NS: TAKEN DECISION TO EXIT US GENERIC PHARMACEUTICAL SEGMENT INITIATES STRATEGIC REALIGNMENT OF US OPERATIONS TO FOCUS ON INNOVATIVE PORTFOLIO FILED VOLUNTARY LIQUIDATION OF MORTON GROVE PHARMACEUTICALS INC, WOCKHARDT USA LLC Source text: [ID:] Further company coverage: WCKH.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter